- Home
- PXLW vs TLPH Comparison
PXLW vs TLPH Comparison
Compare PXLW & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PXLW | TLPH |
|---|---|---|
| Founded | 1997 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.1M | 37.9M |
| IPO Year | 2000 | 2010 |
Fundamental Metrics
Financial Performance| Metric | PXLW | TLPH |
|---|---|---|
| Price | $6.06 | $0.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $14.33 | $6.00 |
| AVG Volume (30 Days) | 25.7K | ★ 218.2K |
| Earning Date | 06-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $693,000.00 | ★ $2,151,000.00 |
| Revenue This Year | $5,066.23 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.46 | $0.38 |
| 52 Week High | $15.42 | $1.57 |
Technical Indicators
Market Signals| Indicator | PXLW | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 47.96 | 36.65 |
| Support Level | $5.67 | $0.76 |
| Resistance Level | $6.77 | $0.79 |
| Average True Range (ATR) | 0.29 | 0.06 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 39.13 | 10.16 |
Price Performance
Historical ComparisonAbout PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.